Prevalence of adenomyosis in patients exposed to hyperestrogenism with a diagnosis of uterine myomatosis, according to the theory of invagination as an etiology of adenomyosis

César A López Lee; Mixtty González Baltazar; Gilberto Guzmán Valdivia; Rodrigo Arredondo Merino

2025, Number 1

<< Back Next >>

Acta Med 2025; 23 (1)

Prevalence of adenomyosis in patients exposed to hyperestrogenism with a diagnosis of uterine myomatosis, according to the theory of invagination as an etiology of adenomyosis

López LCA, González BM, Guzmán VG, Arredondo MR

Full text

How to cite this article

Language: Spanish
References: 12
Page: 28-31
PDF size: 219.68 Kb.

ABSTRACT

Introduction: abnormal uterine bleeding is the first cause of gynecological consultation in fertile age. It has several etiologies (PALM COEIN) and one of the most important is myomatosis and adenomyosis, where the relationship is hyperestrogenism. Objective: demonstrate the relationship between uterine myomatosis and adenomyosis as a consequence of the same etiology, hyperestrogenism. Material and methods: retrospective, observational, descriptive and case-control design, in which 655 clinical records of patients undergoing abdominal hysterectomy with post-surgical pathology results were collected. The procedures were carried out in the period from March 1, 2017 to March 1, 2019, in a private tertiary hospital, Hospital Angeles Pedregal in Mexico City, Mexico. Results: we found that the prevalence of uterine myomatosis and adenomyosis in two years at the Angeles Pedregal Hospital is 31.9%. Conclusions: the etiology of intussusception secondary to hyperestrogenism is related to both pathologies, demonstrating a prevalence of both in 31.9% of the patients studied. Age or pregnancies were not significant during the study.

REFERENCES

Fernández-Díaz JM. Correlación entre el diagnóstico ecográfico ehistopatológico de adenomiosis en pacientes histerectomizadas enel Hospital Nacional Arzobispo Loayza del 2017 al 2021. Handlenet. 2022. Disponible en: https://hdl.handle.net/20.500.12866/11995
Bacon JL. Abnormal uterine bleeding: current classification andclinical management. Obstet Gynecol Clin North Am. 2017; 44 (2):179-193.
Hernández-Valencia M, Valerio-Castro E, TerceroValdez-Zúñiga CL,Barrón-Vallejo J, Luna-Rojas RM. Miomatosis uterina: implicacionesen salud reproductiva. Ginecol Obstet Mex. 2017; 85 (9): 611-633.
Taran FA, Weaver AL, Coddington CC, Stewart EA. Characteristicsindicating adenomyosis coexisting with leiomyomas: a case-controlstudy. Hum Reprod. 2010; 25 (5): 1177-1182. doi: 10.1093/humrep/deq034.
García-Solares J, Donnez J, Donnez O, Dolmans MM. Pathogenesis ofuterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018;109 (3): 371-379.
Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of achallenging gynecologic condition. J Minim Invasive Gynecol. 2016;23 (2): 164-185.
Galicia TLN, Gómez PMG. Prevalencia de adenomiomas y hallazgosasociados en estudios de resonancia magnética de útero en pacientescon miomatosis. Acta Med. 2022; 20 (1): 24-29.
Khalifa T, Abidalla K, Al-Zail N. The significance of pain in leiomyomawith adenomyosis and liomyoma without adenomysis. TobrukUniversity Journal of Medical Sciences (TUJMS). 2023; 5 (1): 63-69.
Garcia L. Isaacson K. (2011). Adenomyosis: review of the literature.J Minim Invasive Gynecol. 2011; 18 (4): 428-437.
Brun JL, Creux H, Gauzere R, Randaoharison P, Dallay D. Tratamientode la adenomiosis. EMC - Ginecología-Obstetricia. 2007; 43 (3): 1-9.
Pron G, Cohen M, Soucie J, Garvin G, Vanderburgh L, Bell S. TheOntario Uterine Fibroid Embolization Trial. Part 1. Baseline patientcharacteristics, fibroid burden, and impact on life. Fertil Steril. 2003;79 (1): 112-119.
Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, TwaddleS et al. Uterine-artery embolization versus surgery for symptomaticuterine fibroids. N Engl J Med. 2007; 356 (4): 360-370.